Tempo reale stimato
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
21,76 USD | -0,93% | +4,91% | -0,14% |
Attività
Numero di dipendenti: 184
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Michael Metzger
CEO | Chief Executive Officer | 53 | 05/05/15 |
Peter Ordentlich
FOU | Founder | 55 | 11/10/05 |
Neil Gallagher
PSD | President | 60 | 10/04/23 |
Keith Goldan
DFI | Director of Finance/CFO | 52 | 13/06/22 |
Chief Tech/Sci/R&D Officer | 52 | - | |
Briggs Morrison
CTO | Chief Tech/Sci/R&D Officer | 65 | 15/06/15 |
Sharon P. Klahre
IRC | Investor Relations Contact | - | 13/06/22 |
Anjali Ganguli
PRN | Corporate Officer/Principal | 48 | 01/05/15 |
Kevin McManus
HRO | Human Resources Officer | - | 01/05/23 |
Luke Albrecht
LAW | General Counsel | 45 | 01/08/16 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Keith Katkin
BRD | Director/Board Member | 52 | 29/03/17 |
Dennis Podlesak
CHM | Chairman | 66 | 01/12/08 |
Pierre Legault
BRD | Director/Board Member | 63 | 04/01/17 |
William Meury
BRD | Director/Board Member | 56 | 25/09/18 |
Briggs Morrison
CTO | Chief Tech/Sci/R&D Officer | 65 | 15/06/15 |
Martin Huber
BRD | Director/Board Member | 64 | 15/09/21 |
Michael Metzger
CEO | Chief Executive Officer | 53 | 05/05/15 |
Jennifer Jarrett
BRD | Director/Board Member | 53 | 25/09/18 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 84 979 686 | 83 411 029 ( 98,15 %) | 0 | 98,15 % |
Coordinate società
Syndax Pharmaceuticals, Inc.
35 Gatehouse Drive Building D
02451, Waltham
+781 419 1400
http://www.syndax.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-0,14% | 1,87 Mrd | |
+20,11% | 42,68 Mrd | |
-2,38% | 42,4 Mrd | |
+45,04% | 40,04 Mrd | |
-6,20% | 28,31 Mrd | |
+5,18% | 24,94 Mrd | |
-20,32% | 18,96 Mrd | |
+30,34% | 12,3 Mrd | |
-3,40% | 11,95 Mrd | |
-4,13% | 11,55 Mrd |
- Borsa valori
- Azioni
- Azione SNDX
- Società Syndax Pharmaceuticals, Inc.